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Abstract
Purpose Infectious complications occur frequently after major
abdominal surgery and have a major influence on patient out-
come and hospital costs. A marker that can rule out postoper-
ative infectious complications (PICs) could aid patient selection
for safe and early hospital discharge. C-reactive protein (CRP)
is a widely available, fast, and cheap marker that might be of
value in detecting PIC. Present meta-analysis evaluates the di-
agnostic value of CRP to rule out PIC following major abdom-
inal surgery, aiding patient selection for early discharge.
Methods A systematic literature search of Medline, PubMed,
and Cochrane was performed identifying all prospective stud-
ies evaluating the diagnostic value of CRP after abdominal
surgery. Meta-analysis was performed according to the PRIS
MA statement.
Results Twenty-two studies were included for qualitative anal-
ysis of which 16 studies were eligible for meta-analysis,
representing 2215 patients. Most studies analyzed the value of
CRP in colorectal surgery (eight studies). The pooled negative
predictive value (NPV) improved each day after surgery up to
90 % at postoperative day (POD) 3 for a pooled CRP cutoff of
159 mg/L (range 92–200). Maximum predictive values for
PICs were reached on POD 5 for a pooled CRP cutoff of
114 mg/L (range 48–150): a pooled sensitivity of 86 % (95 %
confidence interval (CI) 79–91 %), specificity of 86 % (95 %
CI 75–92 %), and a positive predictive value of 64 % (95 % CI
49–77 %). The pooled sensitivity and specificity were signifi-
cantly higher on POD 5 than on other PODs (p<0.001).
Conclusion Infectious complications after major abdominal
surgery are very unlikely in patients with a CRP below
159 mg/L on POD 3. This can aid patient selection for safe
and early hospital discharge and prevent overuse of imaging.
Keywords Abdominal surgery . C-reactive protein .
Diagnostic accuracy . Postoperative infectious complications
Introduction
Postoperative infectious complications (PICs) occur frequent-
ly after major abdominal surgery. PICs have a major influence
on patient outcomes and hospital costs [1–8]. A timely diag-
nosis of infectious complications is associated with a lower
morbidity and mortality rate [7, 9]. However, early clinical
features of postoperative infections are often nonspecific and
difficult to distinguish from the normal postoperative inflam-
matory response related to surgical trauma [9]. The median
time to diagnosis of infectious complications has been report-
ed up to 12 days after surgery, with commonly several days of
delay in retrospect [8].
A biological marker that can predict infectious complica-
tions before clinical signs and symptoms develop could be of
clinical value. The value of such a marker is two-sided; it
could identify patients with a high probability of infectious
complications for early additional investigations, such as an
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abdominal CT scan, or it could identify patients with a low
probability of infectious complications.
C-reactive protein (CRP) is a biological marker that might
be of value in detecting infectious complications. CRP is a
widely available, fast, and cheap marker. CRP levels are
known to increase in the postoperative period, because of
surgical tissue damage. CRP levels tend to normalize rapidly
in patients with an uncomplicated postoperative course due to
its short plasma half-life of 19 h [10, 11].
CRP has been extensively studied for its value in predicting
PIC after major abdominal surgery [12–16]. Several studies
have concluded that CRP is a useful predictor of PIC, but low
positive predictive values have been reported [7, 16–23], mak-
ing CRP a suboptimal marker for ruling in of an infectious
complication. A recent meta-analysis of CRP after gastroesoph-
ageal cancer surgery confirms that CRP values are insufficient
to predict postoperative inflammatory conditions [24].
The value of CRP to rule out the presence of infectious
complications has not yet been studied. In an era of minimal
invasive surgery and enhanced recovery programs, patients are
often discharged early, possibly before clinical signs of deteri-
oration have become evident. A marker that accurately predicts
the absence of postoperative complications could aid patient
selection for safe and early hospital discharge and prevent over-
use of imaging.
The present systematic review and meta-analysis aims to
determine the value of CRP to rule out the presence of infec-
tious complications allowing for safe and early discharge of
patients after major abdominal surgery.
Material and methods
Search strategy
Embase, PubMed, and the Cochrane library were searched up
to the 26 of January 2014. The search strategy consisted of the
MeSH terms and free text words indexed for CRP and major
abdominal surgery. The detailed search strategy is available in
Appendix A. This review was performed according to the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) statement.
Study selection
Inclusion and exclusion criteria were set before the search. Ar-
ticles were considered eligible if the diagnostic accuracy of
CRP for PIC following abdominal or gastrointestinal surgery
was assessed in a prospective study design. If the following
criteria were all met, articles were included: (1) CRP was eval-
uated in the postoperative setting, (2) CRP was evaluated after
major abdominal or gastrointestinal surgical procedures (in-
cluding pancreatic, colorectal, hepatobiliary, esophageal, and
gastric surgery), (3) outcome of interest was the association
between CRP and PIC, and (4) the study design was prospec-
tive. Designs other than prospective design were excluded to
minimize the risk of bias. Studies presenting insufficient data
for extracting 2×2 contingency tables of CRP versus PIC were
also excluded. Original articles in the English, French, German,
Dutch, or Spanish language were considered for inclusion.
Two independent reviewers (SLG and JJA) screened the
titles and abstracts of all papers identified by the search for
eligibility. The full text was obtained of potentially eligible
papers for further evaluation. Reference lists of key articles
and reviews were manually searched to identify additional
articles. In case of disagreement, consensus was reached
through discussion. The inclusion and exclusion of articles
were recorded in a PRISMA flow chart (Fig. 1). Two re-
viewers independently extracted data from the included stud-
ies using a standardized form (SLG, JJA).
Test outcome
CRP levels were compared for patients with and without PIC.
PIC was defined as reported in the studies. If provided, out-
comes were registered for in-hospital stay and 30-day period.
CRP data were recorded whenever mentioned in text, graphs,
or figures of the article. Data regarding measures of diagnostic
accuracy such as sensitivity, specificity, positive predictive
value, negative predictive value, and area under the receiver-
operating curve (AUC) were recorded as reported in the in-
cluded articles. The cutoff value of CRP with presumed
highest discriminatory value was recorded.
Reference standard
The outcome of interest was PIC. PICs were counted per event
and defined as reported in the individual studies. The true
disease status or reference standard, i.e., whether patients ac-
tually developed a PIC, could be determined in multiple ways.
Follow-up, surgery, and radiological imaging were all accept-
ed as reference standard for the diagnosis of PIC. Duration of
clinical follow-up was recorded.
Study design, patient characteristics, and quality
The following data were extracted from included studies:
study period; department of the first author; inclusion period;
study design; country of origin; and patient characteristics
such as number of included patients, the mean or median
age (and range), male to female ratio, time of follow-up, and
the number of true positives (TP), false positives (FP), false
negatives (FN), and true negatives (TN). The methodological
quality of the studies was assessed using the Quality Assess-
ment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool
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[25, 26]. Two by two contingency tables were extracted or
reconstructed for CRP versus PIC for every included study.
Meta-analysis
Meta-analysis was performed with studies that provided
sufficient quantitative data to calculate a contingency ta-
ble for a specified cutoff value of CRP at a specified
postoperative day (POD). A nonlinear mixed model was
used to obtain summary estimates of sensitivity and spec-
ificity with 95 % confidence intervals (CIs) [27]. To com-
pare sensitivity and specificity for each POD, we used the
Wald test for unpaired data. Pooled likelihood ratios
(LRs), positive predictive values (PPVs), and negative
predictive values (NPVs) were calculated for each POD
using the pooled sensitivity and specificity. The geometric
mean with 95 % CI was used to calculate the pooled CRP
value per POD to compare patients with and without PIC.
The pooled cutoff value was calculated using the cutoff
values provided in the individual studies per POD weighted
by their sample size. The pooled area under the curve was
calculated using the individual AUCs weighted by their sample
size. The pooled incidence of PIC was calculated using the
incidence of the individual studies weighted by their sample
size. The pooled incidence was not necessarily the same for
each POD, because for each POD, different studies were avail-
able for pooled analyses.
The pretest probability of developing a PIC can be thought
of as the probability that a patient will develop a PIC based on
bedside evaluation. The posttest probability is the probability
that a patient will develop a PIC based on both bedside eval-
uation and the CRP value. The posttest odds were calculated
by multiplying the pretest odds with the positive and negative
LR. Posttest probabilities for a high and a low CRPs were
calculated and presented in a graph for pretest probabilities
across the range of 0 to 100 %. The underlying assumption
of this graph is that the positive and negative LRs were con-
stant across all pretest probabilities. Using the pooled inci-
dence, representing an average patient, as the pretest probabil-
ity resulted in posttest probabilities for a positive and negative
index test. This incidence can differ across PODs, depending
on the studies available for pooled analysis for each POD.
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All statistical analyses were performed using SPSS
(version 20.0, IBM, Armonk, New York, USA) and SAS
(version 9.3, SAS institute Inc., Cary North Carolina). P
values of <0.05 were considered to indicate statistical
significance.
Results
The search identified 3440 articles after excluding dupli-
cate articles. Articles not meeting the inclusion criteria
based on assessment of the title and abstract (3388) were
excluded. Full text of the potentially eligible 52 articles
was retrieved for detailed examination. Inclusion criteria
were not met in 30 studies. Most of the excluded studies
either had a retrospective design or assessed the value of
CRP in settings other than major abdominal surgery [3,
10, 14, 17–19, 21, 28–38]. The remaining 22 studies were
included for qualitative analysis of which 16 studies could
also be used for meta-analysis (Fig. 1).
Study and patient characteristics
The included articles were published between 1997 and 2013
(Table 1). CRP levels of 2215 patients were examined for their
value in predicting PIC in patients undergoing major abdom-
inal surgery. Postoperative follow-up duration varied from 7
up to 60 days postoperative. Further study characteristics are
summarized in Table 1. Most studies analyzed the value of
CRP in colorectal surgery (eight studies), gastrectomy (three
studies), and esophagectomy (three studies).
Quality of included studies/risk of bias
The quality of the included studies was fairly good
(Figs. 2 and 3). All studies had a representative spectrum
of patients and used an acceptable reference standard.
The time between index and reference test was acceptable
in all studies. The preferred reference standard differed
across studies. In most studies, only patients with elevat-
ed values of inflammatory markers or a clinical suspicion
of complications underwent imaging as diagnostic refer-
ence standard (partial verification). The preferred refer-
ence test differed between patients with a positive index
test (e.g., patients with elevated inflammatory markers)
and negative index test. The preferred reference standard
in patients with a positive index test was diagnostic im-
aging (predominantly computed tomography or conven-
tional radiography with water-soluble contrast), whereas
in patients with a negative index test, clinical follow-up
was the reference standard (differential verification). On-
ly one study avoided partial and differential verification
by performing imaging in all patients [1]. In only oneTa
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study, incorporation of the index test in the reference test
was avoided [33]. None of the studies blinded the
outcome assessors for the reference standard. In only
one study, the index test results were blinded [33]. All
Fig. 2 Methodological quality
summary of the included studies
866 Int J Colorectal Dis (2015) 30:861–873
studies provided information on uninterpretable results
except for one study [22]. One study failed to provide
information on withdrawals [51].
Overall, the risk of bias in the studies is low due to the
nature of the index test (CRP). The outcome of the index test
was independent of the reference standard. In all studies, CRP
measurement was performed in a standardized manner for
study purposes and independent of clinical suspicion of infec-
tion, nor was clinical suspicion of infection documented.
Predictive value of CRP for infectious complications
The incidence of PIC ranged from 5 to 60 % across studies.
The average incidence was 27 % (95 % CI; 26–29 %).
The cutoff level for CRP, which was used to calculate sen-
sitivity, specificity, NPV, and PPV, varied across studies from
48 to 200mg/L. Inmost studies, CRP levels were significantly
higher in patients with infectious complications compared to
patients without complications. This difference increased each
POD (Tables 2 and S2).
Four studies provided sufficient data for meta-analysis
on POD 1, nine studies provided data for POD 3, and six
studies provided data for POD 2, POD 4, and POD 5.
Sensitivity, specificity, PPV, and NPV from the studies
are provided in Table S1 (Appendix). Values of sensitivity
and specificity of the individual studies are plotted for each
POD in Fig. 4a–e. Sensitivity and specificity increased up
to POD 3. The pooled AUC ranged from 0.72 on POD 2 to
0.87 on POD 3 and 0.83 on POD 5. Up to POD 2, the
pooled cutoff value of CRP increased. From POD 3 on-
ward, the pooled cutoff value decreased (Table 3). The
pooled cutoff value for the CRP was 190 mg/L (range
140–240) on POD 2, 159 mg/L (range 92–200) on POD
3, and 114 mg/L (range 48–150) on POD 5.
Pooled diagnostic accuracy variables are listed in Table 3.
The pooled sensitivity and specificity increased per POD.
The lowest pooled sensitivity and specificity were reached
on POD 1 (respectively, 60%; 95%CI (47–71%) and 60%;
95 % CI (43–75 %)). Pooled sensitivity and specificity were
highest on POD 5, 86 % (79–91 %) and 86 % (75–92 %),
and were significantly higher on POD 5 compared to all
other PODs (p<0.001). Using the pooled cutoff values
would lead to 23 % of missed cases (1—sensitivity) of
PIC on POD 3, 20 % on POD 4, and 14 % on POD 5.
The pooled NPV increased each day after surgery at a de-
creasing cutoff of the CRP values (Table 3). The NPV ranged
from 82 % (95 % CI; 68–90 %) on POD 1 to 92 % (95 %CI;
85-96 %) on POD 5. The pooled PPV was low ranging from
41 % (95 % CI; 27–56 %) on POD 1 to 64 % (95 % CI; 49–
77 %) on POD 5.
The negative likelihood ratio (LR−) decreased each POD.
The highest LR−was 0.67 (95%CI; 0.33–1.02) on POD 1, and
the lowest LR− was 0.17 (0.09–0.25) on POD 5. The positive
likelihood ratio (LR+) of CRP increased each POD. The lowest
pooled LR+ was 1.48 (95 % CI; 0.66–2.30) on POD 1, and the
highest LR+ was 6.07 (95 % CI; 2.26–9.89) on POD 5.
Figure 5 presents the (posttest) probability of a PIC for a
patient with a high CRP (green line) and a low CRP (red line)
on POD 3 (Fig. 5a) and POD 5 (Fig. 5b). The cutoff value
between a low and a high CRP was 159 mg/L on POD 3 and
114 mg/L on POD 5. The posttest probability of a PIC in an
average patient with a high CRP on POD 3 was 61 versus
12 % in an average patient with a low CRP. On POD 5, an
average patient with a high CRP had a posttest probability of
55 versus 3 % in an average patient with a low CRP.
Discussion
The objective of this meta-analysis was to evaluate the value
of CRP to rule out PICs after abdominal and gastrointestinal
surgery. In the era of fast-track surgery where patients are
discharged early after surgery and mostly within the first five
PODs, there is a need for a reliable, inexpensive, and widely
available marker that permits safe and early discharge of pa-
tients. A marker reliable enough to rule out the presence of
infectious complications would have a high NPV and a low
negative LR. The NPVof CRP is higher than 90% from day 3
Fig. 3 Methodological quality across studies
Table 2 Mean CRP levels per POD in relation to complications
POD Number of studies
(n=patients)
Mean CRP level
(95 % CI)
Mean CRP level
(95 % CI)
Complicated (infectious) Uncomplicated
1 5 (n=593) 122 (52–288) 67 (36–123)
2 5 (n=641) 195 (91–420) 146 (65–329)
3 5 (n=593) 190 (125–289) 98 (50–195)
4 2 (n=338) 170 (165–174) 95 (78–116)
5 5 (n=663) 188 (71–497) 62 (28–139)
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onward. This suggests that patients with a CRP below
159 mg/L on POD 3 have a low probability of developing a
PIC and could safely be discharged early.
A recent meta-analysis that focused on the diagnostic value
for the presence of anastomotic leakage also found a high NPV
justifying early discharge of patients after colorectal surgery
[52]. However, this meta-analysis is limited by the methodo-
logical design of the included studies. The majority of included
studies have a retrospective design resulting in significant het-
erogeneity. A retrospective study design leads to selective mea-
surement of CRP in patients who are clinically suspected of
having infectious complications (incorporation bias), which
may lead to an overestimation of diagnostic accuracy.
In many European centers, CRP is used in daily practice in
combination with clinical judgment based on history and
physical examination. Combining CRPwith clinical judgment
might increase the (negative) predictive value of CRP even
more. Bedside evaluation during the postoperative course
broadly classifies patients into three categories. Firstly, there
is a group of patients without a clinical suspicion of infectious
complications and, thus, a very low pretest probability. In
these patients, even an elevated CRP value on POD 5 may
not increase the posttest probability enough to warrant a
change in management (e.g., imaging or antibiotics). CRP is
of limited value for these patients. The second group includes
patients in whom the suspicion of infectious complications
based on clinical evaluation is very high. In these patients,
the (posttest) probability will remain sufficiently high, even
for a low CRP value, to justify a change in management. CRP
again has limited value in decision making for these patients.
Finally, predominantly in patients with an intermediate pretest
probability of infectious complications, CRP values are most
likely to determine the need for a change in management. For
high CRP values, the (posttest) probability of an infectious
complication might be sufficiently high to justify a change
in management, while a low CRP value might justify no
change in management. Figure 5 can be used as a decision
aid, in which the physician still needs to determine the
(posttest) probability of a PIC above which he or she feels that
a change in management is warranted.
Studies have also demonstrated that CRP values initially
increase postoperatively and then tend to normalize in patients
without infectious complications around POD 3 [52]. Other
studies have confirmed this suggestion [1, 16, 23, 28, 53, 54].
The results of the present meta-analysis confirm these results
demonstrating that average values of CRP differ between
Fig. 4 Bubble plot of sensitivity and specificity of the individual studies
including the pooled values (circle with dashed line is the pooled AUC
circle with black lines representing the individual studies weighted by
their sample size). a On postoperative day 1. Pooled AUC=0.73. b On
postoperative day 2. Pooled AUC=0.72. c On postoperative day 3.
Pooled AUC=0.87. d On postoperative day 4. Pooled AUC=0.82. e
On postoperative day 5. Pooled AUC=0.83
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patients with and without infectious complications. These
findings suggest that prolonged elevated CRP values are pre-
dictive of infectious complications. CRP might be clinically
useful to aid selection of patients for additional imaging. In
this review, the highest PPVof CRPwas 64% on POD 5. This
PPV would lead to a FP diagnosis in 36 % of patients,
resulting in unnecessary additional imaging in these patients.
Diagnostic test research can be subject to several limitations.
Firstly, knowledge of the CRP value might influence the inter-
pretation of the reference test. For example, the same
intraabdominal fluid collection on a CT scan may be classified
as abscess if the CRP is high, but as ascites if the CRP is low.
Only in one study, blinding for the outcomes of CRP value was
used when determining the presence or absence of PIC [33].
Another difficulty in diagnostic test research is the heterogene-
ity across studies for the selected optimal CRP cutoff value. The
optimal cutoff value is selected by the authors of the individual
studies at the level at which they feel patients with and without
infectious complications are best distinguished. At a higher
cutoff value for the CRP, the sensitivity is higher, but the spec-
ificity is lower. To prevent bias, ideally, the analysis should
have been performed using the same cutoff value of the CRP
in each study. Unfortunately, insufficient data was reported to
use a single optimal cutoff value of the CRP. Pooling study
results even with small differences in the cutoff value have
inevitably biased the results. Diagnostic test results can also
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Fig. 5 a The (posttest) probability
of a PIC is presented for a patient
with a high CRP (green line) and a
low CRP (red line) on POD 3 (a)
and POD 5 (b). The cutoff value
between a low and a high CRP
was 159 mg/L on POD 3 and
114 mg/L on POD 5. The arrows
show that the posttest probability
of a PIC for an average patient
(incidence of PIC 32 %) with a
highCRP on POD3was 61 versus
12 % in an average patient with a
low CRP. The length of the arrows
represents the absolute change in
probability of a PIC in case of a
high or low CRP. On POD 5, an
average patient (incidence of PIC
16 %) with a high CRP had a
posttest probability of 55 versus
3 % in an average patient with a
low CRP. The black diagonal line
at 45° with the x-axis represents
the line of a hypothetical
noninformative test in which the
pretest and posttest probabilities
are equal. The posttest probability
of a PIC can be read from the two
panels for any pretest probability
(i.e., based on bedside evaluation)
and CRP value. Pretest probability
(incidence)=0.32, posttest +
probability=CRP >159 mg/L=
0.61 and posttest – probability=
CRP <159 mg/L=0.12. b Posttest
probability as a function of pretest
probability for the positive and
negative likelihood ratio on POD 5
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be influenced by variation in timing of the reference test: for
example, whether a CT scan to detect an intraabdominal ab-
scess was performed early or late during follow-up. Another
limitation is the difference in the definition of infectious com-
plications between studies. This might influence the incidence
of infectious complications. We aimed to minimize the risk of
bias by including studies that used radiological and/or clinical
evidence to define infectious complications. Finally, the pooled
analysis included patients who underwent different types of
surgery. A bias may have been introduced because the prog-
nostic value of CRP may depend on the type of surgery. It has
been demonstrated that the postoperative increase in CRP is
dependent on the extent of operative trauma. Different types
of surgery could lead to different absolute values of CRP. Nev-
ertheless, this discrepancy between types of abdominal surgery
can only exist in the first 2 days due to the short half-life of CRP
(19 h). The trend where CRP values tend to normalize in pa-
tients without infectious complications around POD 3 has been
demonstrated for various types of surgery [1, 16, 23, 28, 53,
54]. The major advantage of combining different types of ab-
dominal surgery is that a much larger sample size was reached
resulting in more precise estimates.
This meta-analysis evaluated the value of CRP as a predic-
tor to rule out infectious complications. However, when CRP
is combined with bedside clinical evaluation, as used in daily
practice, the NPVof CRP might further increase as illustrated
in Fig. 5. In the literature, no studies were found that assessed
the added value of CRP on top of bedside judgment. Future
studies should aim to determine this added value of CRP.
These studies should also evaluate the diagnostic value of
the change in CRP in the postoperative period instead of fo-
cusing on the absolute value. The change in CRP (e.g., be-
tween POD 2 and 5) may be a stronger predictor than the
absolute CRP value on POD 5. Also, the actual benefit of
early detection and management is assumed but needs to be
determinedmore definitively. In conclusion, CRP values seem
clinically useful to aid patient selection for safe and early
hospital discharge and prevent overuse of imaging.
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